Looking Into Impact Of Beni-Koji Product Recalls On 2024 Financial Results
25/03/2024 05:39
March 25 (Reuters) - Kobayashi Pharmaceutical Co Ltd
4967.T :
* LOOKING INTO IMPACT OF BENI-KOJI PRODUCT RECALLS ON 2024
FINANCIAL RESULTS
Source text for Eikon: ID:nTSoy886c0
Further company coverage: 4967.T
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows